SHAWNA RUBALCABA: Open Payments
NPI 1609418045 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 17 payments from 13 companies in 2025. Trend: 2023 $347 · 2024 $256 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $68 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| TOLMAR, INC. | 2 | $41 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| ConvaTec Inc. | 1 | $33 |
| IMMUNITYBIO, INC. | 1 | $30 |
| Laborie Medical Technologies Corp. | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| 180 Medical, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: JATENZO, PROVENGE, GENTLECATH GLIDE, ANKTIVA, AMS 700, ORGOVYX, Bulkamid, JOURNAVX.
Industry payments across TX — which companies pay providers there.
